These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 10703961
21. 1H T1 and T2 measurements of the MR imaging contrast agents Gd-DTPA and Gd-DTPA BMA at 1.5T. Reichenbach JR, Hackländer T, Harth T, Hofer M, Rassek M, Mödder U. Eur Radiol; 1997; 7(2):264-74. PubMed ID: 9038129 [Abstract] [Full Text] [Related]
22. Gadolinium-Based Contrast Agents and Free Gadolinium Inhibit Differentiation and Activity of Bone Cell Lineages. Strunz F, Stähli C, Heverhagen JT, Hofstetter W, Egli RJ. Invest Radiol; 2024 Jul 01; 59(7):495-503. PubMed ID: 38117137 [Abstract] [Full Text] [Related]
23. Investigation of non-covalent interactions between paramagnetic complexes and human serum albumin by electrospray mass spectrometry. Henrotte V, Laurent S, Gabelica V, Elst LV, Depauw E, Muller RN. Rapid Commun Mass Spectrom; 2004 Jul 01; 18(17):1919-24. PubMed ID: 15329857 [Abstract] [Full Text] [Related]
24. NMRD assessment of Gd-DTPA-bis(methoxyethylamide), (Gd-DTPA-BMEA), a nonionic MRI agent. Adzamli K, Periasamy MP, Spiller M, Koenig SH. Invest Radiol; 1999 Jun 01; 34(6):410-4. PubMed ID: 10353033 [Abstract] [Full Text] [Related]
25. [Comparative studies of the tolerability of gadodiamide, dimeglumine gadopentetate and meglumine gadoterate in MRI tests of the central nervous system]. Chanalet S, Masson B, Boyer L, Laffont J, Bruneton JN. J Radiol; 1995 Jul 01; 76(7):417-21. PubMed ID: 7473375 [Abstract] [Full Text] [Related]
26. Measurement of serum calcium concentration after administration of gadoversetamide in dogs. Wible JH, Hynes MR. Radiology; 2004 Oct 01; 233(1):158-64. PubMed ID: 15454620 [Abstract] [Full Text] [Related]
27. Gadolinium cryptelates as MR contrast agents. Knop RH, Frank JA, Dwyer AJ, Girton ME, Naegele M, Schrader M, Cobb J, Gansow O, Maegerstadt M, Brechbiel M. J Comput Assist Tomogr; 1987 Oct 01; 11(1):35-42. PubMed ID: 3805426 [Abstract] [Full Text] [Related]
28. Maximizing the relaxivity of Gd-complex by synergistic effect of HSA and carboxylfullerene. Zhen M, Zheng J, Ye L, Li S, Jin C, Li K, Qiu D, Han H, Shu C, Yang Y, Wang C. ACS Appl Mater Interfaces; 2012 Jul 25; 4(7):3724-9. PubMed ID: 22704586 [Abstract] [Full Text] [Related]
29. Clearance of liposomal gadolinium: in vivo decomplexation. Unger EC, Fritz TA, Tilcock C, New TE. J Magn Reson Imaging; 1991 Jul 25; 1(6):689-93. PubMed ID: 1823174 [Abstract] [Full Text] [Related]
30. Organ retention of gadolinium in mother and pup mice: effect of pregnancy and type of gadolinium-based contrast agents. Erdene K, Nakajima T, Kameo S, Khairinisa MA, Lamid-Ochir O, Tumenjargal A, Koibuchi N, Koyama H, Tsushima Y. Jpn J Radiol; 2017 Oct 25; 35(10):568-573. PubMed ID: 28730467 [Abstract] [Full Text] [Related]
31. Novel gadolinium(III) polyaminocarboxylate macrocyclic complexes as potential magnetic resonance imaging contrast agents. Chan KW, Barra S, Botta M, Wong WT. J Inorg Biochem; 2004 May 25; 98(5):677-82. PubMed ID: 15134912 [Abstract] [Full Text] [Related]
32. Stability constants and 1H relaxation effects of ternary complexes formed between Gd-DTPA, Gd-DTPA-BMA, Gd-DOTA, and Gd-EDTA and citrate, phosphate, and carbonate ions. Burai L, Hietapelto V, Király R, Tóth E, Brücher E. Magn Reson Med; 1997 Jul 25; 38(1):146-50. PubMed ID: 9211390 [Abstract] [Full Text] [Related]
33. The synthesis and evaluation of macrocyclic gadolinium-DTPA-bis(amide) complexes as magnetic resonance imaging contrast agents. Varadarajan JA, Crofts SP, Carvalho JF, Fellmann JD, Kim SH, Chang CA, Watson AD. Invest Radiol; 1994 Jun 25; 29 Suppl 2():S18-20. PubMed ID: 7928223 [Abstract] [Full Text] [Related]
34. MR imaging of contrast-enhanced porcine myocardial infarction. Assessment of reperfusion and tissue viability. Nilsson S. Acta Radiol Suppl; 1995 Jun 25; 397():1-44. PubMed ID: 7484207 [Abstract] [Full Text] [Related]
35. Poly(l-glutamic acid) Gd(III)-DOTA conjugate with a degradable spacer for magnetic resonance imaging. Lu ZR, Wang X, Parker DL, Goodrich KC, Buswell HR. Bioconjug Chem; 2003 Jun 25; 14(4):715-9. PubMed ID: 12862423 [Abstract] [Full Text] [Related]
36. Determination of gadolinium-based magnetic resonance imaging contrast agents by micellar electrokinetic capillary chromatography. Andrási M, Gáspár A, Kovács O, Baranyai Z, Klekner A, Brücher E. Electrophoresis; 2011 Aug 25; 32(16):2223-8. PubMed ID: 21792999 [Abstract] [Full Text] [Related]
37. Simple method for quantification of gadolinium magnetic resonance imaging contrast agents using ESR spectroscopy. Takeshita K, Kinoshita S, Okazaki S. Chem Pharm Bull (Tokyo); 2012 Aug 25; 60(1):31-6. PubMed ID: 22223372 [Abstract] [Full Text] [Related]
38. Synthesis of DTPA analogues derived from piperidine and azepane: potential contrast enhancement agents for magnetic resonance imaging. Chong HS, Garmestani K, Bryant LH, Brechbiel MW. J Org Chem; 2001 Nov 16; 66(23):7745-50. PubMed ID: 11701031 [Abstract] [Full Text] [Related]
39. Feasibility of gadoteric acid for delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) at the wrist and knee and comparison with Gd-DTPA. Rehnitz C, Klaan B, Do T, Barié A, Kauczor HU, Weber MA. J Magn Reson Imaging; 2017 Nov 16; 46(5):1433-1440. PubMed ID: 28263424 [Abstract] [Full Text] [Related]
40. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging. Li Y, Liu G, Lou X, Chen Z, Ma L. Sci China Life Sci; 2017 Jan 16; 60(1):11-15. PubMed ID: 28078511 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]